JAK2非突变性红细胞瘤: 2026年诊断和管理的最新情况
Naseema Gangat1, Natasha Szuber2, Ayalew Tefferi1
1Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
American journal of hematology
|October 22, 2025
概括
没有突变的JAK2红细胞瘤是一种复杂的疾病,具有多种遗传和获得的原因. 管理侧重于症状控制和心血管风险降低,避免细胞减小疗法.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 内部医学 内部医学
背景情况:
- 没有突变的JAK2红细胞瘤呈现为异质的谱系遗传和获得的条件.
- 区分长期和获得的红细胞瘤症包括分析血红素 (Hct) 和血红蛋白 (Hgb) 水平,以及血清红素 (Epo).
研究的目的:
- 概述JAK2无突变红细胞瘤的诊断方法.
- 审查遗传性和获得性红细胞瘤的原因和治疗方法.
- 突出最近的进展和未来的方向,了解和管理这些条件.
主要方法:
- 通过JAK2突变查排除多细胞血病 (PV).
- 考虑明显的多细胞血症,包括生理异常值和体积收缩导致的相对多细胞血症.
- 评估遗传原因 (例如EPOR,PIEZO1突变) 和获得原因 (例如缺氧,瘤,SGLT2抑制剂等药物).
主要成果:
- 遗传性红细胞瘤包括EPOR,PIEZO1或氧气感应通路等基因的突变.
- 获得的红细胞瘤可以源于缺氧,产生Epo的瘤或某些药物 (例如SGLT2抑制剂).
- 一般不建议进行细胞减小疗法;建议进行瘤切除术以控制症状,优化心血管风险和低剂量阿司匹林.
结论:
- 分子血液学的进步正在改善"异常性红细胞瘤"的特征.
- 进一步的前性研究是必要的,以澄清潜在的病理,并指导最佳的管理策略.
相关概念视频
Disorders of Erythrocytes
2.0K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.0K
Nephrotic Syndrome II : Assessment and Medical Management
197
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
197
Chronic Kidney Disease II: Clinical Manifestations
547
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
547
Acute Pyelonephritis II: Diagnostic Studies and Management
308
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
308
Myocarditis III: Medical Management
173
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
173
Acute Kidney Injury IV: Diagnostic Studies and Prevention
257
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
257


